UPDATE 1-Merrimack Pharma's cancer drug wins FDA approval

Oct 22 (Reuters) - Merrimack Pharmaceutical Inc's pancreatic cancer therapy, Onivyde, became its first ever drug to win approval from the U.S. Food and Drug Administration on Thursday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.